These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33272859)

  • 1. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
    Steve Tsang CC; Wan JY; Chisholm-Burns MA; Li M; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Res Social Adm Pharm; 2021 Aug; 17(8):1469-1477. PubMed ID: 33272859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities associated with Medicare Part D Star Ratings measures among patients with Alzheimer's disease and related dementias.
    Tsang CCS; Zhang X; Barenie RE; Cernasev A; Miller NA; Wan JY; Tsao JW; Wang J
    Medicine (Baltimore); 2023 May; 102(18):e33641. PubMed ID: 37144996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries.
    Browning J; Tsang CCS; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Dong X; Wang J
    J Am Pharm Assoc (2003); 2022; 62(1):142-149. PubMed ID: 34509379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solving racial/ethnic disparities associated with Medicare Part D Star Ratings.
    Dong X; Tsang CCS; Browning JA; Sim Y; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J
    Curr Med Res Opin; 2023 Jul; 39(7):963-971. PubMed ID: 37219396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and ethnic disparities due to Medicare Part D Star Ratings criteria among kidney transplant patients with diabetes, hypertension, and/or dyslipidemia.
    Chisholm-Burns MA; Spivey CA; Tsang CCS; Wang J
    J Manag Care Spec Pharm; 2022 Jun; 28(6):688-699. PubMed ID: 35621720
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of Part D Star Ratings on racial and ethnic disparities in health care costs.
    Tsang CCS; Sim Y; Christensen ML; Wang J
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100250. PubMed ID: 37091627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing racial/ethnic disparities associated with Medicare Part D Star Ratings among population with Alzheimer's disease and related dementias.
    Tsang CCS; Wang J
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(9):1067-1075. PubMed ID: 37551695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.
    Browning JA; Tsang CCS; Zeng R; Dong X; Garuccio J; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Wang J
    Curr Med Res Opin; 2022 Oct; 38(10):1715-1725. PubMed ID: 35852087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure.
    Steve Tsang CC; Browning J; Todor L; Dougherty S; Hohmeier KC; Sam Li M; Borja-Hart N; Hines LE; Wang J
    J Manag Care Spec Pharm; 2021 Aug; 27(8):971-981. PubMed ID: 34337985
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.
    Dong X; Tsang CCS; Zhao S; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Am Health Drug Benefits; 2021 Sep; 14(3):101-109. PubMed ID: 35261713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of star ratings bonus payments on disparities in medication utilization issues.
    Tsang CCS; Garuccio J; Dong X; Sim Y; Wang J
    Explor Res Clin Soc Pharm; 2023 Sep; 11():100323. PubMed ID: 37694164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.
    Browning JA; Tsang CCS; Dong X; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Liu C; Wang J
    BMC Health Serv Res; 2022 Feb; 22(1):159. PubMed ID: 35130899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
    Leslie RS; Tirado B; Patel BV; Rein PJ
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Racial and Ethnic Disparities in Medication Adherence Among Medicare Comprehensive Medication Review Recipients.
    Dong X; Tsang CCS; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Explor Res Clin Soc Pharm; 2021 Sep; 3():. PubMed ID: 35434697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.
    Hung A; Wilson L; Smith VA; Pavon JM; Sloan CE; Hastings SN; Farley J; Maciejewski ML
    JAMA Health Forum; 2024 May; 5(5):e240807. PubMed ID: 38700854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.
    Wang J; Brown LM; Hong SH
    J Am Pharm Assoc (2003); 2012; 52(5):e87-96. PubMed ID: 23023863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Medicare Advantage Star Ratings With Racial, Ethnic, and Socioeconomic Disparities in Quality of Care.
    Meyers DJ; Rahman M; Mor V; Wilson IB; Trivedi AN
    JAMA Health Forum; 2021 Jun; 2(6):e210793. PubMed ID: 35977175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.